Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer

Non-Clinical Senior Lecturer



+44 (0)20 7594 2127j.flanagan




Institute of Reproductive and Developmental BiologyHammersmith Campus





Lab Projects

Dr James Flanagan, completed his PhD in 2002 at the Queensland Institute of Medical Research in Brisbane, Australia, and has pursued postdoctoral work in Cancer Genetics, Epigenetics and Cancer Epigenetics.

Working in the Division of Cancer Epigenetics Unit, his current work is aimed at investigating germline epigenetic alterations as a mechanism for carcinogenesis funded by Breast Cancer Campaign and Cancer Research UK.He was awarded the British Association of Cancer Research Translational Researcher Award in 2011.

Current research is aimed at investigating epigenetic alterations as a mechanism for carcinogenesis, including projects to define tumour subgroups, identification of biomarkers for cancer risk or prognosis in breast and ovarian cancer and investigating the mechanism of transcriptional regulation by DNA methylation outside of the classical promoter CpG Island. Recent work has focussed on the hypothesis that epigenetic variation may be a driver of cancer risk whether by inherent constitutional variation or as a mediator of other cancer risk factors.

We participate in the London Epigenomics Club

Google Scholar

ORCID logo

Selected Publications

Journal Articles

Flanagan JM, Wilson A, Koo C, et al., 2016, Platinum-based chemotherapy induces methylation changes in blood DNA associated with overall survival in ovarian cancer patients., Clinical Cancer Research, ISSN:1078-0432

van Veldhoven K, Polidoro S, Baglietto L, et al., 2015, Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis, Clinical Epigenetics, Vol:7, ISSN:1868-7083

Flanagan JM, Wilhelm-Benartzi CS, Metcalf M, et al., 2013, Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patients, Annals of Oncology, Vol:24, ISSN:0923-7534, Pages:2813-2818

Shenker NS, Polidoro S, van Veldhoven K, et al., 2013, Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking, Human Molecular Genetics, Vol:22, ISSN:0964-6906, Pages:843-851

Brennan K, Garcia-Closas M, Orr N, et al., 2012, Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk, Cancer Research, Vol:72, ISSN:0008-5472, Pages:2304-2313

Flanagan JM, Cocciardi S, Waddell N, et al., 2010, DNA Methylome of Familial Breast Cancer Identifies Distinct Profiles Defined by Mutation Status, American Journal of Human Genetics, Vol:86, ISSN:0002-9297, Pages:420-433

More Publications